| Literature DB >> 31527834 |
W Nicholas Haining1,2, Arlene H Sharpe3,4,5, Martin W LaFleur6,7,8,9, Thao H Nguyen6,8, Matthew A Coxe6,8, Brian C Miller6,7,8,10,11, Kathleen B Yates7,10, Jacob E Gillis6,8, Debattama R Sen7,9,10, Emily F Gaudiano6,8, Rose Al Abosy7, Gordon J Freeman11.
Abstract
CD8+ T cell exhaustion is a state of dysfunction acquired in chronic viral infection and cancer, characterized by the formation of Slamf6+ progenitor exhausted and Tim-3+ terminally exhausted subpopulations through unknown mechanisms. Here we establish the phosphatase PTPN2 as a new regulator of the differentiation of the terminally exhausted subpopulation that functions by attenuating type 1 interferon signaling. Deletion of Ptpn2 in CD8+ T cells increased the generation, proliferative capacity and cytotoxicity of Tim-3+ cells without altering Slamf6+ numbers during lymphocytic choriomeningitis virus clone 13 infection. Likewise, Ptpn2 deletion in CD8+ T cells enhanced Tim-3+ anti-tumor responses and improved tumor control. Deletion of Ptpn2 throughout the immune system resulted in MC38 tumor clearance and improved programmed cell death-1 checkpoint blockade responses to B16 tumors. Our results indicate that increasing the number of cytotoxic Tim-3+CD8+ T cells can promote effective anti-tumor immunity and implicate PTPN2 in immune cells as an attractive cancer immunotherapy target.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31527834 PMCID: PMC6754306 DOI: 10.1038/s41590-019-0480-4
Source DB: PubMed Journal: Nat Immunol ISSN: 1529-2908 Impact factor: 25.606